Cortexin

Cortexin is a neuropeptide complex derived from the cerebral cortex of young animals. It is primarily used for its neuroprotective, nootropic, and cognitive-enhancing properties. The peptide complex works by improving brain function, protecting neurons from damage, and promoting brain repair. Cortexin is widely used in neurology for treating a variety of conditions related to the central nervous system, including neurodegenerative diseases, cognitive decline, and traumatic brain injuries. It also has applications in enhancing memory, learning, and mental performance.

Category

Nootropic/Neuroprotective Peptide Complex

Sequence

Cortexin is a mixture of low-molecular-weight polypeptides and amino acids and as such doesn't gave a defined sequence

Molecular Weight

Cortexin consists of various peptides with low molecular weight between 1000 to 10,000 Da

Molecular Formula

Cortexin is not a single molecule but a complex of peptides and amino acids, so no specific molecular formula is attributed

Half Life

Cortexin does not have a single, quantifiable half-life.

Most Common Uses

Cortexin, a polypeptide extract derived from the cerebral cortex of cattle or pigs, is employed primarily in certain countries, particularly in Russia, for its neuroprotective and nootropic properties. It is used to support recovery from neurological conditions, such as traumatic brain injury, stroke, and cerebral ischemia, by promoting neuronal recovery and improving cognitive function. The peptide is also administered to enhance mental performance in cases of cognitive impairment, including memory disorders and age-related cognitive decline.

Cortexin finds application in pediatric neurology to address developmental delays, attention disorders, and speech impairments in children. Its role in reducing oxidative stress and supporting neuronal metabolism makes it a candidate for managing neurodegenerative conditions, though its use remains limited to specific regions due to varying regulatory approvals.

Mechanism of Action

Cortexin exerts its effects through a multifaceted influence on brain function. Composed of low-molecular-weight peptides and amino acids, it promotes neuronal repair and enhances cognitive processes by modulating neurotransmitter activity. The peptide complex facilitates the release of gamma-aminobutyric acid (GABA) and dopamine, which contribute to balanced neuronal signaling and improved synaptic plasticity. Cortexin also supports neuroprotection by reducing oxidative stress and inhibiting inflammatory processes in brain tissue.

Its ability to enhance cerebral metabolism improves energy utilization in neurons, aiding recovery from neurological damage such as that caused by stroke or traumatic brain injury. Cortexin stimulates neurotrophic factors, fostering neuronal growth and survival. These combined actions underpin its use in treating cognitive impairments and neurological disorders, particularly in regions where it is approved for clinical use.

Structure and Pharmacology

Cortexin consists of a mixture of low-molecular-weight peptides and amino acids, with individual components having molecular weights not exceeding 10,000 Da. Unlike single-sequence peptides, Cortexin lacks a defined amino acid sequence due to its heterogeneous composition. This complexity arises from the extraction process, which isolates biologically active peptides and amino acids from cortical tissue. The absence of a specific molecular formula reflects the diverse nature of its constituents, which include neuropeptides and other bioactive molecules. This structural profile contributes to Cortexin’s stability and its ability to interact with various neurological pathways, supporting its therapeutic applications.

Pharmacologically, Cortexin exerts its effects primarily through neuroprotective and neuromodulatory mechanisms, targeting the central nervous system. Administered via intramuscular injection, it enhances neuronal metabolism by improving energy utilization and increasing the synthesis of neurotrophic factors, which support neuronal growth and repair. The peptide complex modulates neurotransmitter activity, particularly by increasing the release of GABA and dopamine, promoting balanced synaptic function and improved cognitive performance.

Cortexin also reduces oxidative stress and inflammation in brain tissue, offering protection against neuronal damage in conditions like stroke, traumatic brain injury, or cognitive impairment. Its pharmacokinetic profile remains less defined due to its complex composition, but its half-life is short, necessitating daily dosing in clinical practice. Cortexin’s ability to cross the blood-brain barrier allows it to directly influence cerebral processes, making it a valuable agent in neurological treatments where approved, such as in Russia and certain other regions.

Dosages

Cortexin is administered through intramuscular injection, primarily in regions like Russia where it is approved for clinical use. For adults, the typical dose ranges from 10 to 20 milligrams (mg) per day, depending on the condition being treated, such as traumatic brain injury, stroke, or cognitive impairment. Treatment courses generally last 5 to 10 days, with daily injections, and may be repeated after a break of one to two months based on medical evaluation.

In pediatric patients, dosages are adjusted according to body weight, commonly 0.5 mg per kilogram, administered once daily for similar treatment durations. Before injection, the lyophilized powder should be dissolved in sterile water or saline, ensuring proper preparation for safe administration. Dosing regimens vary based on patient needs.

Warnings and Cautions

Cortexin requires careful consideration to ensure safe administration. Patients with known hypersensitivity to Cortexin or its components should avoid its use, as allergic reactions, including rash or swelling, may occur, necessitating immediate medical attention. The peptide is not suitable for people with severe kidney or liver dysfunction, as its metabolism and clearance may be affected, potentially leading to adverse effects. Pregnant or breastfeeding women should avoid using Cortexin, as safety data in these populations remain limited.

Pediatric administration, while common for conditions like developmental delays, demands precise weight-based dosing to prevent complications. Mild side effects, such as local irritation at the injection site, may occur, but persistent discomfort warrants medical evaluation. Patients should be carefully monitored during treatment to adjust their dose or discontinue use if unexpected symptoms occur.

Research & Trials

Neuroprotective Effects of Cortexin in Developmental Brain Injury

Cortexin Improves Cognitive Function in Children

Neuroprotective Potential of Cortexin in Brain Ischemia

Sourcing

USA

LIMITLESS LIFE NOOTROPICS aka Biotech

Use Discount Code: EP20

SCANTIFIX

Use Discount Code: Exploringpeptides

Canada

BIOSLAB

Use Discount Code: EP10

Europe

DNLABResearch

Use Discount Code: EP15

Australia

LVLUPHEALTH

References

[1] Kurkin, D. V., Bakulin, D. A., Morkovin, E. I., Petrov, V. I., Strygin, A. V., Smirnov, A. V., Shmidt, M. V., Gorbunova, J. V., Kolosov, Y. A., Ivanova, O. V., Krysanov, I. S., Dzhavakhyan, M. A., Zaborovsky, A. V., Saparova, V. B., Makarenko, I. E., Drai, R. I., Lugovik, I. A., Verlov, N. A., & Burdakov, V. S. (2025). Neurotropic Effects of Cortexin on Models of Mental and Physical Developmental Delay. Biomedicines, 13(4), 860. https://doi.org/10.3390/biomedicines13040860

[2] Zykov, V. P., Serebrennikova, E. B., Panchenko, T. N., Sycheva, Y. B., Presnyakova, S. N., Mazur, E. L., Salova, M. N., Golubeva, E. S., & Khromova, S. K. (2018). Rezul'taty mul'titsentrovogo issledovaniia éffektivnosti primeneniia korteksina pri kognitivnykh disfunktsiiakh u deteĭ [Results of a multicenter study on the efficacy of cortexin in treatment of cognitive dysfunction in children]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 118(3), 27–31. https://doi.org/10.17116/jnevro20181183127-31

[3] Kurkin, D. V., Bakulin, D. A., Morkovin, E. I., Kalatanova, A. V., Makarenko, I. E., Dorotenko, A. R., Kovalev, N. S., Dubrovina, M. A., Verkholyak, D. V., Abrosimova, E. E., Smirnov, A. V., Shmidt, M. V., & Tyurenkov, I. N. (2021). Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats. PloS one, 16(7), e0254493. https://doi.org/10.1371/journal.pone.0254493

Related articles

SLU-PP-915: Benefits, Research & Comparison with SLU-PP-332

Adalank vs Selank: Differences, Benefits and Effects

Adamax vs Semax: Comparison, Benefits, and Effects

Common Mistakes When Reconstituting Peptides

Peptides Vs Proteins: What’s The Difference?

What Are Peptides and How Do They Work?